Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -3.5x - -3.9x | -3.7x |
| Selected Fwd P/E Multiple | -4.4x - -4.9x | -4.6x |
| Fair Value | kr7.49 - kr8.28 | kr7.89 |
| Upside | 17.0% - 29.4% | 23.2% |
| Benchmarks | - | Full Ticker |
| Demant A/S | - | CPSE:DEMANT |
| Coloplast A/S | - | CPSE:COLOB |
| 2cureX AB (publ) | - | OM:2CUREX |
| Ambu A/S | - | CPSE:AMBUB |
| CVRx, Inc. | - | NasdaqGS:CVRX |
| ViroGates A/S | - | CPSE:VIRO |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| DEMANT | COLO B | 2CUREX | AMBU B | CVRX | VIRO | |||
| CPSE:DEMANT | CPSE:COLOB | OM:2CUREX | CPSE:AMBUB | NasdaqGS:CVRX | CPSE:VIRO | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 14.6% | 5.5% | NM- | -5.8% | NM- | NM- | ||
| 3Y CAGR | 2.4% | 1.5% | NM- | -1.6% | NM- | NM- | ||
| Latest Twelve Months | 2.5% | 0.3% | 15.6% | 37.0% | -45.5% | -18.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 10.1% | 21.2% | -489.5% | 5.0% | -204.0% | -260.2% | ||
| Prior Fiscal Year | 13.1% | 19.5% | -883.6% | 3.5% | -104.8% | -173.1% | ||
| Latest Fiscal Year | 12.9% | 18.7% | -1103.4% | 4.4% | -116.9% | -200.9% | ||
| Latest Twelve Months | 12.9% | 17.8% | -1333.3% | 5.8% | -116.9% | -200.9% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 12.9x | 22.0x | -0.5x | 33.7x | -2.6x | -3.0x | ||
| Price / LTM Sales | 2.2x | 5.8x | 9.1x | 5.5x | 4.0x | 7.1x | ||
| LTM P/E Ratio | 17.4x | 32.5x | -0.7x | 95.2x | -3.5x | -3.5x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -3.5x | 17.4x | 95.2x | |||||
| Historical LTM P/E Ratio | -25.2x | -11.3x | -3.5x | |||||
| Selected P/E Multiple | -3.5x | -3.7x | -3.9x | |||||
| (x) LTM Net Income | (14) | (14) | (14) | |||||
| (=) Equity Value | 50 | 53 | 55 | |||||
| (/) Shares Outstanding | 7.7 | 7.7 | 7.7 | |||||
| Implied Value Range | 6.49 | 6.83 | 7.17 | |||||
| FX Rate: DKK/DKK | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 6.49 | 6.83 | 7.17 | 6.40 | ||||
| Upside / (Downside) | 1.4% | 6.8% | 12.1% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DEMANT | COLO B | 2CUREX | AMBU B | CVRX | VIRO | |
| Value of Common Equity | 52,870 | 157,031 | 23 | 32,233 | 207 | 50 | |
| (/) Shares Outstanding | 213.0 | 225.2 | 25.1 | 266.4 | 26.1 | 7.7 | |
| Implied Stock Price | 248.20 | 697.40 | 0.93 | 121.00 | 7.95 | 6.40 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 248.20 | 697.40 | 0.93 | 121.00 | 7.95 | 6.40 | |
| Trading Currency | DKK | DKK | SEK | DKK | USD | DKK | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |